NEOGENOMICS INC
NEO·64049M209·US·Common Stock·Healthcare - Diagnostics & Research-13D/G
NEO (NEOGENOMICS INC) is held by 133 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($148.1M), VANGUARD PORTFOLIO MANAGEMENT LLC ($56.6M), FIRST TRUST ADVISORS LP ($45.7M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 77 funds bought NEO.
133
Holders
(14 Elite)
$699.3M
Total Value
58% (133)
Consensus
77 buying - 56 selling
13F: Insider & Congress:
Who's Trading
InsiderADAunan Greg DSell $321KAug 4, 2026
ActivistFTFirst Trust Portfolios L.P.7.8%Jul 30, 2026
InsiderTATETRAULT LYNN A.Sell $59KJun 15, 2026
InsiderTATETRAULT LYNN A.Sell $60KJun 9, 2026
ActivistGLGreenhouse Funds LLLP7.1%May 15, 2026
ActivistMPMathew P. Arens10.8%May 7, 2026
InsiderSWStone WarrenExercise 6K shMay 2, 2026
Top Holders
Showing 1-20 of 145
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer